CC
DICE

Centiva Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Centiva Capital’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,806
Closed -$920K – 2254
2023
Q2 		$920K Buy
+19,806
New +$685K 0.02% 592

Centiva Capital's DICE Position: Q3 2023 in Review

Centiva Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 19,806 shares — an estimated $920K sold.

Centiva Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $920K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Centiva Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 19,806 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $920K.
  • Centiva Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Centiva Capital's DICE Therapeutics, Inc. Common Stock position peaked at $920K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.